Biliary Tract and GE Junction Cancers – Tanios Bekaii-Saab, MD, FACP, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019

Biliary Tract and GE Junction Cancers – Tanios Bekaii-Saab, MD, FACP, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019

Friday February 8, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Tanios Bekaii-Saab, MD, Professor, Mayo Clinic College of Medicine and Science, discuss biliary tract and GE junction cancer clinical highlights from ASCO GI 2019

Non Small Cell Lung Cancer (NSCLC) – Edward Garon, MD, and Robert Figlin, MD, discuss promising agents in development for the management of NSCLC from ASCO20

Thursday June 11, 2020

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Edward Garon, MD, Director of Thoracic Oncology Program, Jonsson Comprehensive Cancer Center, Associate Professor of Medicine, David Geffen School of Medicine, UCLA, discuss promising agents in development for the management of NSCLC from ASCO20

Waldenstrom macroglobulinemia – Constantine Tam, MD, and Robert Figlin, MD, discuss recent clinical advances in the treatment of Waldenstrom macroglobulinemia from ASCO20

Monday June 8, 2020

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Constantine Tam, MD, Haematologist and Disease Group Lead, Low Grade Lymphoma and Chronic Lymphocytic Leukemia, Peter MacCallum Cancer Centre, discuss the progress in Waldenstrom macroglobulinemia from ASCO20

Featured Videos

Sara Hurvitz, MD, discusses the recently announced results of Monarch E and PALLAS adjuvant trials

Edward Garon, MD, examines the ADAURA clinical study regarding adjuvant treatment in NSCLC

Nancy Lin, MD, on the design and outcomes of the HER2CLIMB study regarding metastatic breast cancer